Daratumumab for immune thrombotic thrombocytopenic purpura

Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening thrombotic microangiopathy. It is caused by a severe ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 motifs, 13) deficiency due to circulating autoantibodies, and is associated with significant morbidity a...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, Jana, Kremer Hovinga, Johanna A., Pfleger, Claudia, Hegemann, Inga, Stehle, Gregor, Holbro, Andreas, Studt, Jan-Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945322/
https://www.ncbi.nlm.nih.gov/pubmed/34551063
http://dx.doi.org/10.1182/bloodadvances.2021005124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945322/
https://www.ncbi.nlm.nih.gov/pubmed/34551063
http://dx.doi.org/10.1182/bloodadvances.2021005124

Ejemplares similares